MannKind Corporation Posts In-Line Q4; Expense Falls 35% By: Benzinga via Benzinga February 24, 2015 at 17:34 PM EST MannKind Corp. (NASDAQ: MNKD) gained in Tuesday's extended session after the drug company posted a fourth-quarter loss in line ... Read More >>